IP Verse

Sorbonne Université opposition analysis

COMPANY ANALYSIS

Latest patents of Sorbonne Université opposed by its competitors

Patent:
EP3920970
Grant Date:
Nov 23, 2022
Title:
Method For Treating Checkpoint Inhibitors Induced Adverse Events
Oppositions:
1
Patent:
EP3096781
Grant Date:
Nov 2, 2022
Title:
Agents For Use In The Treatment Of Retinal Inflammation
Oppositions:
1
Patent:
EP3768304
Grant Date:
Oct 12, 2022
Title:
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
Oppositions:
6
Patent:
EP3116529
Grant Date:
Oct 27, 2021
Title:
Interleukin-2 For Treating Food Allergy
Oppositions:
1
Patent:
EP3212200
Grant Date:
Jan 20, 2021
Title:
Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases
Oppositions:
1
Patent:
EP3443979
Grant Date:
May 27, 2020
Title:
Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus
Oppositions:
1
Patent:
EP2790706
Grant Date:
May 8, 2019
Title:
Phytoecdysones For Use In Improving The Muscle Quality Of Obese And/Or Sarcopenic Mammals
Oppositions:
1
Patent:
EP2683395
Grant Date:
Aug 1, 2018
Title:
Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders
Oppositions:
1

Competitors of Sorbonne Université

STRAWMAN LIMITED

BAYER INTELLECTUAL PROPERTY GMBH / BAYER AKTIENGESELLSCHAFT

GATESIP

Want to track Sorbonne Université?

Feel free to send us a message here and we will get back to you